Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure
- PMID: 2296621
- DOI: 10.1007/BF02245782
Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure
Abstract
The discriminative stimulus properties of (+)-lysergic acid diethylamide (LSD) and lisuride hydrogen maleate (LHM), were compared in a three-choice, water reinforced (FR 20) situation in which rats were required to press one lever following LSD (0.08 mg/kg), a second lever following LHM (0.04 mg/kg), and a third lever following saline. Reliable drug-appropriate responding was established in 72 sessions. Dose-response tests with LSD and LHM indicated that, as dose increased, the per cent of responding on the lever associated with the particular training drug also increased; little or no cross-transfer occurred between LSD and LHM. In generalization tests, the serotonin (5-HT) agonist quipazine substituted for LSD but not LHM while the dopamine (DA) agonist apomorphine mimicked LHM but not LSD; an unrelated compound, pentylenetetrazol (PTZ), produced responding on the saline-appropriate lever. In combination tests, 5-HT antagonists (e.g., BC-105 and low doses of pirenperone) blocked responding on the LSD lever while DA antagonists (e.g., haloperidol and much higher doses of pirenperone) blocked LHM-appropriate responding. These data suggest that the three-lever (D-D-N) procedure is similar to, but can be more sensitive than the two-lever (D-N) procedure (because it can differentiate between LSD and LHM); they therefore at least partially support the hypothesis that three-choice discriminations can be conceptualized as two separate, two-choice (D-N) discriminations (Jarbe and Swedberg 1982). The results also confirm suggestion that the stimulus effects of LSD and LHM are mediated by different mechanisms; the primary action of LSD is serotonergic (5-HT2), while that of LHM is dopaminergic (White 1986).
Similar articles
-
The role of dopamine and serotonin in the discriminative stimulus effects of lisuride.J Pharmacol Exp Ther. 1982 May;221(2):421-7. J Pharmacol Exp Ther. 1982. PMID: 7077537
-
Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.Pharmacol Biochem Behav. 1986 Feb;24(2):365-79. doi: 10.1016/0091-3057(86)90367-9. Pharmacol Biochem Behav. 1986. PMID: 3952127
-
Discriminative stimulus properties of lergotrile.J Pharmacol Exp Ther. 1984 Jul;230(1):47-52. J Pharmacol Exp Ther. 1984. PMID: 6146709
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
-
Stimulus properties of dopaminergic drugs: comparisons involving selective agonists and antagonists.Psychopharmacol Ser. 1988;4:44-56. doi: 10.1007/978-3-642-73223-2_4. Psychopharmacol Ser. 1988. PMID: 3293045 Review.
Cited by
-
Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.Neurosci Lett. 2022 Sep 25;788:136836. doi: 10.1016/j.neulet.2022.136836. Epub 2022 Aug 10. Neurosci Lett. 2022. PMID: 35963476 Free PMC article.
-
μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges.Front Pharmacol. 2023 Oct 11;14:1239159. doi: 10.3389/fphar.2023.1239159. eCollection 2023. Front Pharmacol. 2023. PMID: 37886127 Free PMC article. Review.
-
The behavioral pharmacology of hallucinogens.Biochem Pharmacol. 2008 Jan 1;75(1):17-33. doi: 10.1016/j.bcp.2007.07.018. Epub 2007 Jul 20. Biochem Pharmacol. 2008. PMID: 17977517 Free PMC article. Review.
-
Psychedelic-like Properties of Quipazine and Its Structural Analogues in Mice.ACS Chem Neurosci. 2021 Mar 3;12(5):831-844. doi: 10.1021/acschemneuro.0c00291. Epub 2021 Jan 5. ACS Chem Neurosci. 2021. PMID: 33400504 Free PMC article.
-
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis.Psychopharmacology (Berl). 2005 Jul;180(3):427-35. doi: 10.1007/s00213-005-2183-9. Epub 2005 Feb 19. Psychopharmacology (Berl). 2005. PMID: 15723230
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources